Immunoblotting validated that HDAC inhibitors downregulate the expression level of the c-Myc protein, which supports Ewing sarcoma tumorigenesis (Supplementary Fig. S9; refs. 78, 79). This evidence concerns the gene MYC and Ewing sarcoma.